Journal of Neuroimmunology
Volume 220, Issue 1 , Pages 69-78 , 30 March 2010

Reduction of cell proliferation and potentiation of Fas-induced apoptosis by the selective kappa-opioid receptor agonist U50 488 in the multiple myeloma LP-1 cells

  • Céline Kerros

      Affiliations

    • C.K. is a recipient of the Ministère de l'enseignement supérieur et de la recherche.
    • ,
  • Isabelle Brood
    • ,
  • Brigitte Sola
    • ,
  • Philippe Jauzac

      Affiliations

    • In memory of Philippe Jauzac.
    • ,
  • Stéphane Allouche

      Affiliations

    • Corresponding Author InformationCorresponding author. Laboratoire de Biochimie, Centre Hospitalier et Universitaire, Avenue côte de nacre, 14033 Caen cedex, France. Tel.: +33 231065419; fax: +33 231064985.

Received 17 November 2009 ,Revised 12 January 2010 ,Accepted 19 January 2010.

References 

  1. Allouche S, Hasbi A, Ferey V, Sola B, Jauzac P, Polastron J. Pharmacological delta1- and delta2-opioid receptor subtypes in the human neuroblastoma cell line SK-N-BE: no evidence for distinct molecular entities. Biochem. Pharmacol. 2000;59:915–925
  2. Bayer BM, Daussin S, Hernandez M, Irvin L. Morphine inhibition of lymphocyte activity is mediated by an opioid dependent mechanism. Neuropharmacology. 1990;29:369–374
  3. Bidlack JM, Saripalli LD, Lawrence DM. kappa-Opioid binding sites on a murine lymphoma cell line. Eur. J. Pharmacol. 1992;227:257–265
  4. Borner C, Stumm R, Hollt V, Kraus J. Comparative analysis of mu-opioid receptor expression in immune and neuronal cells. J. Neuroimmunol. 2007;188:56–63
  5. Carr DJ, Kim CH, deCosta B, Jacobson AE, Rice KC, Blalock JE. Evidence for a delta-class opioid receptor on cells of the immune system. Cell. Immunol. 1988;116:44–51
  6. Chatzaki E, Makrigiannakis A, Margioris AN, Kouimtzoglou E, Gravanis A. The Fas/FasL apoptotic pathway is involved in kappa-opioid-induced apoptosis of human endometrial stromal cells. Mol. Hum. Reprod. 2001;7:867–874
  7. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 1987;162:156–159
  8. Chuang TK, Killam KF, Chuang LF, Kung HF, Sheng WS, Chao CC, et al. Mu opioid receptor gene expression in immune cells. Biochem. Biophys. Res. Commun. 1995;216:922–930
  9. Chuang LF, Killam KF, Chuang RY. Induction and activation of mitogen-activated protein kinases of human lymphocytes as one of the signaling pathways of the immunomodulatory effects of morphine sulfate. J. Biol. Chem. 1997;272:26815–26817
  10. Chudapongse N, Kim SY, Kramer RE, Ho IK. Nonspecific effects of the selective kappa-opioid receptor agonist U-50, 488H on dopamine uptake and release in PC12 cells. J. Pharmacol. Sci. 2003;93:372–375
  11. Delogu G, Moretti S, Antonucci A, Marandola M, Tellan G, Sale P, et al. Apoptogenic effect of fentanyl on freshly isolated peripheral blood lymphocytes. J. Trauma. 2004;57:75–81
  12. Egle A, Villunger A, Kos M, Bock G, Gruber J, Auer B, et al. Modulation of Apo-1/Fas (CD95)-induced programmed cell death in myeloma cells by interferon-alpha 2. Eur. J. Immunol. 1996;26:3119–3126
  13. Fuchs BA, Pruett SB. Morphine induces apoptosis in murine thymocytes in vivo but not in vitro: involvement of both opiate and glucocorticoid receptors. J. Pharmacol. Exp. Ther. 1993;266:417–423
  14. Gabrilovac J, Balog T, Andreis A. Dynorphin-A(1-17) decreases nitric oxide release and cytotoxicity induced with lipopolysaccharide plus interferon-gamma in murine macrophage cell line J774. Biomed. Pharmacother. 2003;57:351–358
  15. Garcia-Fuster MJ, Ferrer-Alcon M, Martin M, Kieffer BL, Maldonado R, Garcia-Sevilla JA. Effects of constitutive deletion of opioid receptors on the basal densities of Fas and Fas-associated protein with death domain (FADD) in the mouse brain: a delta-opioid tone inhibits FADD. Eur. Neuropsychopharmacol. 2007;17:366–374
  16. Gaveriaux C, Peluso J, Simonin F, Laforet J, Kieffer B. Identification of kappa- and delta-opioid receptor transcripts in immune cells. FEBS Lett. 1995;369:272–276
  17. Heagy W, Teng E, Lopez P, Finberg RW. Enkephalin receptors and receptor-mediated signal transduction in cultured human lymphocytes. Cell. Immunol. 1999;191:34–48
  18. Kazmi SM, Mishra RK. Opioid receptors in human neuroblastoma SH-SY5Y cells: evidence for distinct morphine (mu) and enkephalin (delta) binding sites. Biochem. Biophys. Res. Commun. 1986;137:813–820
  19. Kim YR, Lee SY, Shin BA, Kim KM. Panax ginseng blocks morphine-induced thymic apoptosis by lowering plasma corticosterone level. Gen. Pharmacol. 1999;32:647–652
  20. Knapp RJ, Malatynska E, Fang L, Li X, Babin E, Nguyen M, et al. Identification of a human delta opioid receptor: cloning and expression. Life Sci. 1994;54:L463–L469
  21. Lawrence DM, Bidlack JM. The kappa opioid receptor expressed on the mouse R1.1 thymoma cell line is coupled to adenylyl cyclase through a pertussis toxin-sensitive guanine nucleotide-binding regulatory protein. J. Pharmacol. Exp. Ther. 1993;266:1678–1683
  22. Li JG, Chen C, Liu-Chen LY. N-Glycosylation of the human kappa opioid receptor enhances its stability but slows its trafficking along the biosynthesis pathway. Biochemistry. 2007;46:10960–10970
  23. Mansour A, Burke S, Pavlic RJ, Akil H, Watson SJ. Immunohistochemical localization of the cloned kappa 1 receptor in the rat CNS and pituitary. Neuroscience. 1996;71:671–690
  24. Mansson E, Bare L, Yang D. Isolation of a human kappa opioid receptor cDNA from placenta. Biochem. Biophys. Res. Commun. 1994;202:1431–1437
  25. Martin-Kleiner I. The effect of opioid agonists of delta-class DSLET, mu-class DAMGO, kappa-class U-69593 and an opioid antagonist, naloxone, on MTT activity of NALM-1 leukemic cells. Biomed. Pharmacother. 2002;56:458–462
  26. Martin-Kleiner I, Bidlack JM. The synthetic kappa-opioid agonist (-)U50, 488 does not affect calcium transport into R1.1 mouse thymoma cell line. Int. J. Immunopharmacol. 1999;21:133–140
  27. McCarthy L, Wetzel M, Sliker JK, Eisenstein TK, Rogers TJ. Opioids, opioid receptors, and the immune response. Drug Alcohol Depend. 2001;62:111–123
  28. Miller B. delta opioid receptor expression is induced by concanavalin A in CD4+ T cells. J. Immunol. 1996;157:5324–5328
  29. Pan YX. Diversity and complexity of the mu opioid receptor gene: alternative pre-mRNA splicing and promoters. DNA Cell Biol. 2005;24:736–750
  30. Polastron J, Mur M, Mazarguil H, Puget A, Meunier JC, Jauzac P. SK-N-BE: a human neuroblastoma cell line containing two subtypes of delta-opioid receptors. J. Neurochem. 1994;62:898–906
  31. Porthe G, Frances B, Verrier B, Cros J, Meunier JC. The kappa-opioid receptor from human placenta: hydrodynamic characteristics and evidence for its association with a G protein. Life Sci. 1988;43:559–567
  32. Risdahl JM, Khanna KV, Peterson PK, Molitor TW. Opiates and infection. J. Neuroimmunol. 1998;83:4–18
  33. Rozen S, Skaletsky H. Primer3 on the WWW for general users and for biologist programmers. Methods Mol. Biol. 2000;132:365–386
  34. Shahabi NA, Sharp BM. Delta opioid agonists inhibit proliferation of highlypurified murine CD4+ and CD8+ T-cells. Adv. Exp. Med. Biol. 1995;373:29–36
  35. Shahabi NA, McAllen K, Matta SG, Sharp BM. Expression of delta opioid receptors by splenocytes from SEB-treated mice and effects on phosphorylation of MAP kinase. Cell. Immunol. 2000;205:84–93
  36. Stefano GB, Melchiorri P, Negri L, Hughes TK, Scharrer B. [D-Ala2]deltorphin I binding and pharmacological evidence for a special subtype of delta opioid receptor on human and invertebrate immune cells. Proc. Natl. Acad. Sci. U. S. A. 1992;89:9316–9320
  37. Tegeder I, Grosch S, Schmidtko A, Haussler A, Schmidt H, Niederberger E, et al. G protein-independent G1 cell cycle block and apoptosis with morphine in adenocarcinoma cells: involvement of p53 phosphorylation. Cancer Res. 2003;63:1846–1852
  38. Vassou D, Bakogeorgou E, Kampa M, Dimitriou H, Hatzoglou A, Castanas E. Opioids modulate constitutive B-lymphocyte secretion. Int. Immunopharmacol. 2008;8:634–644
  39. Viallard JF, Lacombe F, Belloc F, Pellegrin JL, Reiffers J. Molecular mechanisms controlling the cell cycle: fundamental aspects and implications for oncology. Cancer. Radiother. 2001;5:109–129
  40. Wang JB, Johnson PS, Persico AM, Hawkins AL, Griffin CA, Uhl GR. Human mu opiate receptor. cDNA and genomic clones, pharmacologic characterization and chromosomal assignment. FEBS Lett. 1994;338:217–222
  41. Wybran J, Appelboom T, Famaey JP, Govaerts A. Suggestive evidence for receptors for morphine and methionine-enkephalin on normal human blood T lymphocytes. J. Immunol. 1979;123:1068–1070
  42. Yin D, Mufson RA, Wang R, Shi Y. Fas-mediated cell death promoted by opioids. Nature. 1999;397:218

PII: S0165-5728(10)00015-9

doi: 10.1016/j.jneuroim.2010.01.010

Journal of Neuroimmunology
Volume 220, Issue 1 , Pages 69-78 , 30 March 2010

Article Tools

* Image Usage & Resolution